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Introduction: Cardiovascular disease (CVD) is a leading cause of death in sub-Saharan Africa (SSA), with
annual deaths expected to increase to 2 million by 2030. Currently, most national health systems in SSA are not
adequately prepared for this epidemic. This is especially so in slum settlementswhere access to formal healthcare
and resources is limited.
Objective: To develop and introduce amodel of cardiovascular prevention in the slums ofNairobi by integrating
public health and private sector approaches.
Study design: Two non-profit organizations that conduct public health research, Amsterdam Institute for
Global Health and Development (AIGHD) and African Population and Health Research Center (APHRC),
collaborated with private-sector Boston Consulting Group (BCG) to develop a service delivery package for
CVDprevention in slum settings. A theoreticmodel was designed based on the integration of public and private
sector approaches with the focus on costs and feasibility.
Results: The final model includes components that aim to improve community awareness, a home-based
screening service, patient and provider incentives to seek and deliver treatment specifically for hypertension, and
adherence support. The expected outcomes projected by this model could prove potentially cost effective and
affordable (1 USD/person/year). The model is currently being implemented in a Nairobi slum and is closely
followed by key stakeholders in Kenya including the Ministry of Health, the World Health Organization
(WHO), and leading non-governmental organizations (NGOs).
Conclusion: Through the collaboration of public health and private sectors, a theoretically cost-effective model
was developed for the prevention of CVD and is currently being implemented in the slums of Nairobi. If results
are in line with the theoretical projections and first impressions on the ground, scale-up of the service delivery
package could be planned in other poor urban areas in Kenya by relevant policymakers and NGOs.
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C
ardiovascular disease (CVD) is the leading cause
of mortality worldwide (1) with up to 80% of
global CVD deaths occurring in low- and middle-
income countries (LMICs) such as Kenya. By 2030, 2
million annual CVD deaths are expected in sub-Saharan
Africa (SSA) (2).
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The rise of CVDs in LMICs is driven mainly by
globalization, industrialization, and urbanization (3),
linked to an increased prevalence of CVD risk factors
such as tobacco use, alcohol consumption, physical
inactivity, and adoption of diets that are high in salt,
sugar, and ‘unhealthy’ fat/oils.
The prevalence of behavioral and physiological risk
factors for CVD is higher in urban than in rural areas (4).
As the urban population in SSA is projected to increase
from 395 million to 1.23 billion by 2050 (5), the burden of
CVD in this region is bound to increase (6).
In Kenya, almost 70% of the urban population lives
in slums or slum-like conditions where access to formal
health services is limited (7). With existing healthcare
services suffering from the ‘double burden of disease’
of endemic infectious diseases and emerging chronic
diseases, CVDs are treated predominantly at late stages
after complications have occurred (8). This makes care
unnecessarily costly and less effective (810).
CVD is not only a public health problem, it is also an
economic one (11). At the household and community
levels, patients and their families often fall into poverty
because of high healthcare-related expenditures (mostly
out-of-pocket) for chronic conditions, as well as loss of
income due to illness. At the macro level, losing young,
productive people makes CVD a serious threat to the
economies of SSA, an important issue considering that
CVD deaths in SSA tend to occur 10 or more years
earlier than in Europe and North America (12, 13).
Individual interventions for CVD prevention are both
cost effective and scalable, even in resource-constrained
settings (1417). However, evidence is limited on cost-
effective and sustainable community-based CVD preven-
tion programs in LMICs in general (8, 18), and in severely
resource-constrained settings such as slum settlements in
particular.
The integration of public health and private-sector
approaches to tackle CVD prevention could prove useful
since, like CVD itself, prevention is closely linked to
economic constraints. Such an approach could lead to
the development of sustainable and scalable solutions
that can be adapted locally to benefit public health in
resource-poor settings in SSA.
The aim of this article is to describe a study design that
integrates public health and private-sector approaches to
lead to the development and introduction of a service
delivery package for CVD prevention among urban poor
in SSA.
Study design
Two public health research organizations, the Amsterdam
Institute for Global Health and Development (AIGHD)
and the African Population and Health Research Center
(APHRC), collaborated with a private-sector partner,
Boston Consulting Group (BCG), to develop a service
delivery package for primary prevention of CVD that is
suitable for implementation in slum settings in Nairobi,
Kenya. We were particular about developing a model
that was at least in theory, cost effective. Previous
studies in this setting (19) and results of an intervention
project to improve patient access to treatment for hyper-
tension and diabetes in primary care settings (APHRC,
unpublished data), as well as a comprehensive literature
review (20) informed the conceptual framework outlined
in Fig. 1. This framework examines the flow of people
from awareness of cardiovascular risk factors like
hypertension and access to treatment, to adherence and
successful blood pressure control. We show the main
bottlenecks contributing to low service utilization and loss
Fig. 1. Cascade of care for hypertension and CVD risk reduction.
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to follow-up, that is, becoming aware of CVD risk, access-
ing screening, seeking treatment, and complying with
medication.
We constructed various alternatives of service delivery
packages aimed at minimizing the bottlenecks identified
in the theoretical framework (see Additional file 1). As
evidence of community-based CVD prevention programs
in LMICs is relatively limited, we borrowed important
lessons from HIV prevention and control programs to
address CVD (21). For instance, HIV control programs
engage the community, involving fellow patients as peer
educators and utilizing community health workers
(CHWs) in home-based care, with demonstrated specific
benefit to patient wellbeing and clinical outcomes (22).
Overall, the cost and potential impact of the various
alternative service delivery packages we considered were
based on existing literature as well as our knowledge of
the study area. The various alternative service delivery
packages were then discussed with various CVD preven-
tion stakeholders including policy makers, academic
experts, program implementers, researchers, and field
staff from previous projects, as well as local community
representatives. Healthcare provision in Kenya is shared
equally by the public and private sectors (23). Therefore,
we aimed to include the feedback of representatives
from both types of service providers. The objective was
to ensure that each component of the service delivery
package would address critical bottlenecks in the patient
care continuum in a manner that is practical and accept-
able within Nairobi slums.
Finally, the service delivery packages were ranked
based on their theoretical cost effectiveness to determine
the package most likely to succeed.
Results
The outcome of the abovementioned process was the
final selection of a service delivery package for primary
prevention of CVD that comprised four elements: (i)
increasing community awareness through announcements
at community gatherings and religious services, and a
local community radio jingle; (ii) improving access to
screening for CVD risk factors such as hypertension
through household visits; (iii) increasing treatment seek-
ing through vouchers for free treatment and CHW incen-
tives to follow up patients and persuade them to visit the
clinic; and (iv) improving long-term compliance by set-
ting up patient support groups, subsidizing medication
through these groups, providing incentives for CHWs,
and sending text messages (SMS) to remind patients of
clinic appointments, medication use, and healthy lifestyles
(Fig. 2). The final service delivery package for prevention
of CVD has a specific focus on hypertension but it also
includes other risk factors such as diabetes and obesity.
This is because hypertension is the single most important
risk factor for CVD (1).
For the package to remain potentially cost effective, a
prioritization strategy is needed whereby only people aged
35 years and above would be screened. This population
represents the group at highest risk: almost three-quarters
of people with hypertension in the community are in this
age category (APHRC, unpublished data).
Overall, we estimated that the final selected service
delivery package could avert 248391 DALYs and cost
less than one USD/person in the community (Fig. 3)
resulting in a cost effectiveness of 7601,200 USD/DALY
averted. This makes the service delivery package, in
theory, a highly cost-effective intervention for CVD risk
Fig. 2. Components of the final service delivery package.
Introducing a model of cardiovascular prevention
Citation: Glob Health Action 2013, 6: 22510 - http://dx.doi.org/10.3402/gha.v6i0.22510 3
(page number not for citation purpose)
prevention, with the potential to be sustainable in the
resource-constrained settings.
The selected service delivery package began being
implemented in August 2012 as the SCALE-UP Study
(Sustainable model for Cardiovascular health by Adjust-
ing Lifestyle and treatment with Economic perspective in
settings of Urban Poverty) in Korogocho, a Nairobi slum
with a total population of 35,000. More than 100 CHWs
and field interviewers have been trained during an intense
1-week training, after a pilot was completed. Staff have
been recruited mainly from the local community with the
assistance of the Ministry of Health who supplied us with
a list of CHWs in the area. The training sessions were
given by experienced APHRC staff and contained a wide
range of topics such as clinical information on CVD and
risk factors, techniques of screening and counselling, and
ethical and practical aspects of the project. These led to
an increase in knowledge among the participants from a
pre-training score of 25/100 to a post-training score of
80/100). The CHWs are incentivized by receiving a fixed
amount of money (approximately 3USD) for every person
they screen and refer to the local clinic, and who demo-
nstrates long-term compliance. The estimated total amount
of payments and workload is in line with the guidelines
for respectively compensation and duties of CHWs from
the Ministry of Health. Therefore, introduction of the
model in the existing public healthcare structure is
feasible. Local clinic staffs were trained during a 1-day
course on simple guidelines for treating people based on
absolute cardiovascular risk, to narrow the treatment
gap (24). These staff also showed a significant increase in
knowledge with the pre-training score of 38/100 rising
to 78/100 to post-training score. To ensure sustainability,
these staffs are recruited mainly from existing healthcare
services where they work as nurses and clinical officers.
Because the clinics are open 2 days per week, they are
able to adjust their existing work schedules for the rest of
the week.
Enrolment of participants is ongoing, with close to
5,000 people 35 years and above already screened. This
has led to approximately 900 referrals and 500 patients
visiting the clinic. These numbers are close to the projected
estimates. The population has reacted positively to the
household screening with overall gratitude toward CHWs
and low rates of refusals (3%). However, the fieldwork
remains challenging due to the dynamic circumstances of
the slum setting with high insecurity and mobility.
To measure the health impact of this initiative, two
cross-sectional surveys (before and after, at least 1 year
apart) will be conducted in Korogocho and the control
site, Viwandani, a similar slum 10 km away. The usual
standard of care for prevention and control of CVD in
the control slum will be assessed. All resource utilization
and related costs will be captured to assess the total cost
of the intervention and estimate both affordability and
feasibility. It is expected that the final evaluation of the
project will reveal whether the service delivery package
selected is cost-effective and acceptable.
From the study onset, we have maintained regular
contact with key stakeholders, including the Ministry of
Health, City Council of Nairobi, WHO, and leading non-
governmental organizations (NGOs) such as Me´decins
sans Frontie`res. In order to facilitate potential scale-up
to other settings, a manual is being developed to show
how a similar package of interventions can be designed,
Fig. 3. Potential cost calculations of the final service delivery package.
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implemented, and adapted to different contexts, should
this intervention be proven cost effective.
Conclusion
Through the collaboration of public health and private
sector, a theoretically cost-effective model was developed
for prevention of CVD, which is currently being imple-
mented in a Nairobi slum. Collaboration between public
health researchers and management consultants intro-
duced innovative aspects to the design and selection of
interventions. Based on early HIV screening approaches
(25), public health researchers initially did not consider
household screening as a realistic option. However, after
discussions with the management consultants and a
systematic comparison of different combinations of ser-
vice delivery packages, door-to-door screening seemed
likely to be more cost effective and sustainable within a
comprehensive group of interventions than traditional
stand-alone screening sites. The underpinning hypothesis
is that active engagement of people is needed when pro-
ducts and projects, such as hypertension screening, are
relatively unknown. Additionally, the household ap-
proach significantly reduces costs by combining aware-
ness raising and screening, two activities that would
otherwise be considered separately.
Performance-based payments and incentives as part of
prevention and control strategies for CVD are relatively
new in the public health sector in SSA. In low-resource
settings, they may play an important role in making
effective use of limited resources. The downside is that
rigorous follow-up is required to prevent beneficiaries and
program staff from manipulating the incentive system,
especially in settings of extreme poverty such as slums.
Furthermore, we experienced some resistance from key
stakeholders such as CHWs to the idea of an incentive-
based payment, preferring the old system of fixed
remuneration.
If results are in line with the theoretical projections and
first impressions on the ground, scale-up of the service
delivery package could be extended to other poor urban
areas in Kenya by relevant policymakers and NGOs. In
time, this approach may also prove to be sustainable and
scalable elsewhere in Africa.
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